346 related articles for article (PubMed ID: 22954722)
1. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
[TBL] [Abstract][Full Text] [Related]
2. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
3. Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.
Vettraino M; Manerba M; Govoni M; Di Stefano G
Anticancer Drugs; 2013 Sep; 24(8):862-70. PubMed ID: 23797802
[TBL] [Abstract][Full Text] [Related]
4. Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.
Manerba M; Vettraino M; Fiume L; Di Stefano G; Sartini A; Giacomini E; Buonfiglio R; Roberti M; Recanatini M
ChemMedChem; 2012 Feb; 7(2):311-7. PubMed ID: 22052811
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
6. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells.
Han X; Sheng X; Jones HM; Jackson AL; Kilgore J; Stine JE; Schointuch MN; Zhou C; Bae-Jump VL
J Hematol Oncol; 2015 Jan; 8():2. PubMed ID: 25631326
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers.
Arora R; Schmitt D; Karanam B; Tan M; Yates C; Dean-Colomb W
Oncotarget; 2015 Jan; 6(2):662-78. PubMed ID: 25575825
[TBL] [Abstract][Full Text] [Related]
9. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
Awad AB; Barta SL; Fink CS; Bradford PG
Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406
[TBL] [Abstract][Full Text] [Related]
10. Involvement of stress activated protein kinases (JNK and p38) in 1,25 dihydroxyvitamin D3-induced breast cell death.
Brosseau CM; Pirianov G; Colston KW
Steroids; 2010 Dec; 75(13-14):1082-8. PubMed ID: 20654640
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells.
Fiume L; Vettraino M; Carnicelli D; Arfilli V; Di Stefano G; Brigotti M
Biochem Biophys Res Commun; 2013 Jan; 430(2):466-9. PubMed ID: 23237800
[TBL] [Abstract][Full Text] [Related]
13. Targeting aspartate aminotransferase in breast cancer.
Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
Manerba M; Di Ianni L; Fiume L; Roberti M; Recanatini M; Di Stefano G
Eur J Pharm Sci; 2015 Jul; 74():95-102. PubMed ID: 25930121
[TBL] [Abstract][Full Text] [Related]
15. LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis.
Wang ZY; Loo TY; Shen JG; Wang N; Wang DM; Yang DP; Mo SL; Guan XY; Chen JP
Breast Cancer Res Treat; 2012 Feb; 131(3):791-800. PubMed ID: 21452021
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function.
Mouradian M; Kikawa KD; Dranka BP; Komas SM; Kalyanaraman B; Pardini RS
Mol Carcinog; 2015 Sep; 54(9):810-20. PubMed ID: 24729481
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
Knouzy B; Dubourg L; Baverel G; Michoudet C
J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
[TBL] [Abstract][Full Text] [Related]
18. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
19. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
20. Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Rabi T; Wang L; Banerjee S
Breast Cancer Res Treat; 2007 Jan; 101(1):27-36. PubMed ID: 17028990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
